Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Temozolomide in Patients With Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: a Multicenter, Single-arm, Phase II Trial

NCT01847235 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01847235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01847235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Temozolomide in Patients With Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: a Multicenter, Single-arm, Phase II Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
March 31, 2016
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic oligoastrocytoma, anaplastic oligodendroglioma